openPR Logo
Press release

U.S. Insomnia Market worth 4.24 Billion USD by 2021

03-06-2017 03:49 PM CET | Health & Medicine

Press release from: Markets and Markets

The report "U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021", provides a detailed overview of the major drivers, restraints, challenges, current market trends, and strategies impacting the U.S. insomnia market along with the estimates and forecasts of the revenue.

The U.S. insomnia market is projected to reach USD 4.24 Billion by 2021 from USD 3.38 Billion in 2016, at a CAGR of 4.6% during the forecast period. This growth can be attributed to the launch of new drugs for the treatment of insomnia and government support to control rising insomnia cost. However, due to the erosion in branded drugs sales and growing adoption of generics attributed to their low cost and equal efficacy as compared to branded products may hinder the growth of the market.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=55727597

Based on the type of treatment, the U.S. insomnia market is segmented into non-pharmacological treatment and pharmacological treatment market. The pharmacological treatment market is further is categorized into prescription sleep aids and over-the-counter sleep aids. The OTC sleep aids segment is expected to grow at the highest CAGR during the forecast period. Owing to their easier availability and low price as compared to prescription sleep aids. Furthermore, the publicity regarding the side effects of the prescription sleep aids has also steered the patients towards OTC sleep aid options.

The prescription sleep aids segment is categorised into non-benzodiazepines, benzodiazepines, orexin antagonists, melatonin receptor agonists, and other prescription sleep aids. The orexin antagonist sleep aids segment is expected to grow at the highest CAGR during the forecast period due to its greater efficacy than non-benzodiazepine and benzodiazepine drugs. The OTC sleep aids is further segmented into antihistamines, melatonin, valerian roots, and other herbal and dietary supplements.

The non-pharmacological treatment market is categorised into cognitive behavioural therapy for insomnia (CBTI), hypnotherapy, and other alternative therapies. The other alternative therapies include exercise/ yoga, acupuncture, biofeedback, bright light therapy, music therapy, and aroma therapy. Most of these therapies are given in combination with CBTI and hypnotherapies in order to provide better results for insomnia patients. CBTI is the highly recommended treatment option for insomnia patients due to its most effective use with multiple approaches such as relaxation training, cognitive therapy, stimulus control (SC), sleep restriction therapy (SRT), sleep hygiene, biofeedback, and others that help doctors to understand and cure patient comprehensively. CBTI is followed by hypnotherapy, due to its advantage of curing insomnia with its root cause.

Some of the major players in the U.S. insomnia market market include Eisai Co., Ltd. (Japan), Meda Consumer Healthcare Inc. (U.S.), Merck & Co., Inc. (U.S.), Pernix Therapeutics Holdings (U.S.), Pfizer, Inc. (U.S.), Sanofi S.A. (France), Takeda Pharmaceutical Company Ltd. (Japan), and Vanda Pharmaceuticals, Inc (U.S.).

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Insomnia Market worth 4.24 Billion USD by 2021 here

News-ID: 457931 • Views: 400

More Releases from Markets and Markets

Cryogenic Insulation Market Competitive Landscape Analysis and Forecast To 2023
The cryogenic insulation market size is estimated to be USD 2.3 billion in 2018 and is projected to reach USD 3.3 billion by 2023, at a CAGR of 7.20% between 2018 and 2023. Rising environmental awareness is contributing to the growth of the market. Volatile raw material price is the key challenge faced in the cryogenic insulation market. Growing demand for cryogenic technologies in space applications has created various opportunities
Plastic Antioxidants Market- Future Demand, Market Analysis upto 2024
The global plastic antioxidants market size is projected to reach USD 2.8 billion by 2024 from USD 2.2 billion in 2019, at a CAGR of 5.0% between 2019 and 2024. Plastic antioxidants are stabilizing agents that prevent oxidation or reactions promoted by free radicals, oxygen, or peroxides in plastics. They are added to plastics to prevent their decomposition. Antioxidants do not eliminate oxidative degradation completely, but they substantially prevent auto-oxidation
Electric Vehicle Adhesives Market and Its Key Opportunities and Challenges
The Electric Vehicle Adhesives Market size is estimated at USD 223 million in 2019 and is projected to reach USD 2,158 million by 2024, at a CAGR of 57.0% between 2019 and 2024. The application of EV adhesives are increasing due to various requirements by the automakers, such as bonding similar and dissimilar materials, substitution of traditional substrates materials by synthetic substrates and the increasing focus on environmental concerns. The
Smart Farming Market is Growing Due to the Increasing Automation & Digitization …
The growth in the trends of mechanization in the agriculture industry, focus on livestock monitoring to improve the efficiency of farms, and governments’ support for modern agricultural techniques stimulate the global smart farming market. The North American and European regions are projected to dominate the global smart farming market during the forecast period. These regions are the largest markets for innovative technologies used for agriculture. Considering the huge opportunities in these

All 5 Releases


More Releases for CBTI

Insomnia Market Expected to Expand at a Steady CAGR through 2016 - 2026
Global Insomnia Market: Brief Account  The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases such
Insomnia Market to Witness an Outstanding Growth by 2026
Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases
Insomnia Market Research Report - Growth, Trends & Forecasts 2016 - 2024
The Insomnia Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s
Insomnia Market to Record Sturdy Growth by 2026
The Insomnia Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s
Insomnia Market: Industry Analysis and Opportunity Assessment
Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases